EXC-001

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameEXC-001
Drug Alias NameEXC-001PF-6473871PF-06473871
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionConnective tissue growth factor inhibitors
TargetsConnective tissue growth factor
Therapy Area/IndicationsHypertrophic skin diseaseCicatrix, HypertrophicCicatrix
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHypertrophic skin diseaseCicatrix, HypertrophicCicatrix

Other Information

ATC CodeN/A
Related LinksN/A